Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.12
+0.21 (0.84%)
At close: May 9, 2025, 4:00 PM
24.46
-0.66 (-2.63%)
After-hours: May 9, 2025, 4:07 PM EDT
Pacira BioSciences Employees
As of December 31, 2024, Pacira BioSciences had 790 total employees, including 788 full-time and 2 part-time employees. The number of employees increased by 78 or 10.96% compared to the previous year.
Employees
790
Change (1Y)
78
Growth (1Y)
10.96%
Revenue / Employee
$889,585
Profits / Employee
-$131,300
Market Cap
1.16B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PCRX News
- 17 hours ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRA) and Encourages Investors to Learn More About the Investigation - Accesswire
- 3 days ago - Pacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Pacira BioSciences Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 days ago - Pacira BioSciences, Inc. (PCRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRA) And Encourages Investors to Connect - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Stockholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis - GlobeNewsWire
- 10 days ago - Pacira BioSciences, Inc. (PCRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire